acetylcarnitine has been researched along with Ureteral Obstruction in 1 studies
Acetylcarnitine: An acetic acid ester of CARNITINE that facilitates movement of ACETYL COA into the matrices of mammalian MITOCHONDRIA during the oxidation of FATTY ACIDS.
Ureteral Obstruction: Blockage in any part of the URETER causing obstruction of urine flow from the kidney to the URINARY BLADDER. The obstruction may be congenital, acquired, unilateral, bilateral, complete, partial, acute, or chronic. Depending on the degree and duration of the obstruction, clinical features vary greatly such as HYDRONEPHROSIS and obstructive nephropathy.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chen, DQ | 1 |
Cao, G | 1 |
Chen, H | 1 |
Argyopoulos, CP | 1 |
Yu, H | 1 |
Su, W | 1 |
Chen, L | 1 |
Samuels, DC | 1 |
Zhuang, S | 1 |
Bayliss, GP | 1 |
Zhao, S | 1 |
Yu, XY | 1 |
Vaziri, ND | 1 |
Wang, M | 1 |
Liu, D | 1 |
Mao, JR | 1 |
Ma, SX | 1 |
Zhao, J | 1 |
Zhang, Y | 1 |
Shang, YQ | 1 |
Kang, H | 1 |
Ye, F | 1 |
Cheng, XH | 1 |
Li, XR | 1 |
Zhang, L | 1 |
Meng, MX | 1 |
Guo, Y | 1 |
Zhao, YY | 1 |
Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
---|---|---|---|---|---|---|---|
Effect of Dapagliflozin on Metabolomics and Cardiac Mechanics in Chronic Kidney Disease[NCT05719714] | Phase 1/Phase 2 | 60 participants (Anticipated) | Interventional | 2023-11-01 | Recruiting | ||
[information is prepared from clinicaltrials.gov, extracted Sep-2024] |
1 other study available for acetylcarnitine and Ureteral Obstruction
Article | Year |
---|---|
Identification of serum metabolites associating with chronic kidney disease progression and anti-fibrotic effect of 5-methoxytryptophan.
Topics: Acetylcarnitine; Animals; Canavanine; Carnitine; Case-Control Studies; Disease Models, Animal; Disea | 2019 |